Zymeworks (ZYME) FCF Margin (QoQ) (2022 - 2026)
Powered by 
Analysis
Zymeworks (ZYME) FCF Margin (QoQ) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.15 Bn | 1.88 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 121,152.00 |
| Mar 31, 2026 | -147,654.00 |
| Dec 31, 2025 | -31,578.00 |
| Sep 30, 2025 | -13,909.00 |
| Jun 30, 2025 | 3,672.00 |
| Mar 31, 2025 | 12,192.00 |
| Dec 31, 2024 | -9,241.00 |
| Sep 30, 2024 | 9,059.00 |
| Jun 30, 2024 | 24,450.00 |
| Mar 31, 2024 | -45,768.00 |
| Dec 31, 2023 | 34,434.00 |
| Sep 30, 2023 | -16,129.00 |
| Jun 30, 2023 | 13,207.00 |
| Mar 31, 2023 | -33,553.00 |
| Dec 31, 2022 | 291,309.00 |
| Sep 30, 2022 | -175,611.00 |
| Jun 30, 2022 | 205,272.00 |
| Mar 31, 2022 | -241,793.00 |